Corpus Intelligence IC Memo — GEORGE E. WEEMS MEMORIAL HOSPITAL 2026-04-26 13:27 UTC
IC Memo — GEORGE E. WEEMS MEMORIAL HOSPITAL
Investment Committee Memorandum | FL | 25 beds | Grade D | EBITDA uplift $500K
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

GEORGE E. WEEMS MEMORIAL HOSPITAL

CCN 101305 | FRANKLIN, FL | 25 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

GEORGE E. WEEMS MEMORIAL HOSPITAL is a 25-bed under-performing / distressed in FRANKLIN, FL with $6.7M in net patient revenue and a -64.6% operating margin. The hospital serves a payer mix of 50.8% Medicare, 2.3% Medicaid, and 46.9% commercial.

Thesis: Turnaround. Our ML models identify $500K in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -64.6% to -57.1% (+751bps).

Net Revenue HCRIS$6.7M
Current EBITDA COMPUTED$-4.3M
Operating Margin COMPUTED-64.6%
Occupancy HCRIS3.3%
Revenue / Bed COMPUTED$266K
Net-to-Gross HCRIS50.5%
Distress Probability ML62.6%

2. Market Context & Competitive Position

261
FL Hospitals
3.2%
State Median Margin
41
Comparable Hospitals

FL has 261 Medicare-certified hospitals with a median operating margin of 3.2%. The target's margin of -64.6% places it below the state median. Among 41 size-comparable peers (12-50 beds), the median margin is -0.7%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (12-50), prioritizing same-state peers. 41 hospitals in the comp set.

HospitalStateBedsRevenueMargin
GEORGE E. WEEMS MEMORIAL HOSPI (Target)FL25$6.7M-64.6%
MARINERS HOSPITALFL16$74.3M17.0%
MEDICAL CENTER OF DELTONAFL43$45.4M-30.2%
HENDRY REGIONAL MEDICAL CENTERFL25$41.1M-20.8%
ED FRASER MEMORIAL HOSPITALFL21$40.7M17.8%
DESOTO MEMORIAL HOSPITALFL49$38.5M-18.7%
MIAMI JEWISH HEALTH SYSTEMS IFL32$36.6M-50.0%
ADVENTHEALTH WAUCHULAFL25$35.5M10.0%
NORTHWEST FLORIDA COMMUNITY HOFL25$35.2M-2.4%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $500K (751bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$140K+210bp18mo
Denial Rate Reduction12.0%6.5%$136K+205bp12mo
Cost to Collect4.5%2.5%$133K+200bp12mo
A/R Days Reduction5200.0%3800.0%$81K+122bp9mo
Clean Claim Rate88.0%96.0%$10K+14bp6mo

5. EBITDA Bridge

Net Collection Rate
$140K
Denial Rate Reduction
$136K
Cost to Collect
$133K
A/R Days Reduction
$81K
Clean Claim Rate
$10K
Total EBITDA Uplift$500K
Current EBITDA$-4.3M
+ RCM Uplift+$500K
Pro Forma EBITDA$-3.8M
Current Margin-64.6%
Pro Forma Margin-57.1%
WC Released (1x)$255K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-6.6M$-23.4M0.00x-100.0%
Base (11x exit)10.0x11.0x$-6.6M$-27.8M0.00x-100.0%
Bull Case9.0x11.0x$-6.0M$-28.3M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-6.0M$-32.7M0.00x-100.0%
Bear Case11.0x10.0x$-7.3M$-23.7M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-7.3M$-28.4M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumLow occupancyAt 3.3%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 62.6% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 41 hospitals with 12-50 beds
  • Same-state prioritization (n=42)
  • Comp margins: P25=-23.9% / P50=-0.7% / P75=9.4%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.